Bibliography
- GABRIEL B, STUBBS M, BERGNER A et al: Design of benzamidine,-type inhibitors of Factor Xa. J. Med. Chem. (1998) 41:4240–4250.
- HARA T, YOKOYAMA A, ISHIHARA H, YOKOYAMA Y, NAGAHARA T, IWAMOTO M: DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for Factor Xa. Thromb. HaemosL (1994) 71:314–319.
- BRANDSTETTER H, KeHNE A, BODE W et al.: X-ray structure of active site-inhibited clotting Factor Xa. Implications for drug design and substrate recogni-tion. J. Biol. Chem. (1996) 271:29988–29992.
- ••Provides a structural explanation for the specificity of FactorXa.
- STUBBS MT, HUBER R, BODE W: Crystal structures ofFactor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of Factor Xa and selectivity against thrombin. FEBS Lett. (1995) 375:103–107.
- ZHU B-Y, SCARBOROUGH RM: Recent advances in inhibitors of Factor Xa in the prothrombinase complex. Curr. Opin. Cardiovasc. Pulm. Ren. Invest. Drugs (1999) 1:63–88.
- ••A comprehensive review on the most recent classes ofFactor Xa inhibitors.
- KAMATA K, H HK, HONMA T, IWAMA T, KIM SH:Structural basis for chemical inhibition of human blood coagulation Factor Xa. Proc. Nati Acad. Sci. USA (1998) 95:6630–6635.
- QUAN ML, ELLIS CD, LIAUW AY et al: Design andsynthesis of isoxazoline derivatives as Factor Xa inhibitors. 2. J. Med. Chem. (1999) 42:2760–2773.
- •Structure-activity studies on biaryl inhibitors with some pharmakokinetic data.
- MENEAR K: Progress towards the discovery of orally active, thrombin inhibitors. Curr. Med. Chem. (1998) 5:457–468.